1998
DOI: 10.1006/bbrc.1998.9810
|View full text |Cite
|
Sign up to set email alerts
|

Non-Enzymatic Production of Nitric Oxide (NO) from NO Synthase Inhibitors

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

4
43
0

Year Published

1999
1999
2019
2019

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 61 publications
(47 citation statements)
references
References 33 publications
4
43
0
Order By: Relevance
“…Similar parallel effects of L-arginine and L-NAME were reported previously under various (patho)physiological conditions (Henningsson et al, 2000;Vasilijević et al, 2007a). These analogous effects were attributed to the action of NO originating from non-enzymatic (Moroz et al, 1998) and iNOS-mediated (Henningsson et al, 2000) production in the presence of NOS inhibitors, or they may be related to other NO-independent metabolic effects of an L-arginine analog (Krippeit-Drews et al, 1996). Moreover, following in vivo administration of NOS inhibitors, the response may result from their systemic effects, and not only from local, peripheral effects (Bult et al, 1990;Jun et al, 1995).…”
Section: P<0001 Pgc-1α/ppars In Skeletal Muscle In the Coldsupporting
confidence: 84%
“…Similar parallel effects of L-arginine and L-NAME were reported previously under various (patho)physiological conditions (Henningsson et al, 2000;Vasilijević et al, 2007a). These analogous effects were attributed to the action of NO originating from non-enzymatic (Moroz et al, 1998) and iNOS-mediated (Henningsson et al, 2000) production in the presence of NOS inhibitors, or they may be related to other NO-independent metabolic effects of an L-arginine analog (Krippeit-Drews et al, 1996). Moreover, following in vivo administration of NOS inhibitors, the response may result from their systemic effects, and not only from local, peripheral effects (Bult et al, 1990;Jun et al, 1995).…”
Section: P<0001 Pgc-1α/ppars In Skeletal Muscle In the Coldsupporting
confidence: 84%
“…However, there are several reports, with different model systems, concerning the same effect of L-NAME treatment as that seen after L-arginine treatment. Conflicting observations in experiments with the NOSs inhibitor L-NAME are explained by non-enzymatic production of NO during incubation with L-NAME in the presence of NADPH, GSH and ascorbate (Moroz et al, 1998). Henningsson et al (Henningsson et al, 2000) showed that chronic L-NAME treatment in diabetic rats blocked constitutive NOSs that evoked iNOS-derived NO production to compensate for NO level, while Krippeit-Drews et al (KrippeitDrews et al, 1996) reported that L-NAME can also act directly, not via intracellular messengers.…”
Section: Discussionmentioning
confidence: 92%
“…NO has also been reported to be generated in biological systems by a nonenzymatic pathway, which involves chemical reduction of inorganic nitrite (9 -13). Nonenzymatic NO generation has been demonstrated in vivo, for example, in the mouth (14), stomach (15), on the surface of the skin (16), in the ischemic heart (12), and in infected nitrite-containing urine (17), as well as under certain conditions involving NOS inhibitors (9) and substrates (10).…”
mentioning
confidence: 99%